ClinicalTrials.gg
Sign In

Paraproteinemias clinical trials

The registry lists 69 studies for Paraproteinemias across more than 10 countries. 22 are recruiting or about to start. 14 of them are mainly about Paraproteinemias (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29. Counting its 6 narrower conditions too, such as Multiple Myeloma: 4,362 studies, 906 open.

Get an email when these change. Save the Paraproteinemias studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
27
Recruiting
13
Active, not recruiting
7
Not yet recruiting
7
Withdrawn
6
Status unknown
4

Phase

Phase 2
26
Phase 1
18
Phase 3
7
Early Phase 1
2
Phase 4
1

Where

United States
39
France
9
Greece
9
China
7
United Kingdom
7
Australia
6

Who runs them

Hellenic Society of Hematology (5) · Alexion Pharmaceuticals, Inc. (2) · Zhujiang Hospital (2) · Ohio State University Comprehensive Cancer Center (2) · Seagen Inc. (2) · Pfizer (2) · University Hospital, Brest (2) · Baylor College of Medicine (2)

What is being tested here

Drugs under test in Paraproteinemias studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexamethasone416
Daratumumab304
Lenalidomide226
Pomalidomide202
Isatuximab114
Florbetaben f-18101
Nirogacestat101
Bortezomib013
Anselamimab022
Cyclophosphamide002

Coming up

2phase 3 studies under way
8studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8

Who these studies take

Of the 13 Paraproteinemias studies recruiting now, 7 (54%) set no upper age limit and 3 (23%) stop at 75 or younger. 1 (8%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (23%) take healthy volunteers.

Recruiting studies that take each age, of 13
AgeWomenMen
101 (8%)1 (8%)
1811 (85%)11 (85%)
3012 (92%)12 (92%)
4013 (100%)13 (100%)
5012 (92%)12 (92%)
6512 (92%)12 (92%)
7512 (92%)12 (92%)
8510 (77%)10 (77%)

Across all 69 studies, recruiting or not: 14% stop at 75 or younger and 1% at 65; 12% take children; 0% are for women only and 0% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 69. Browse all 69 → or search them.